Raymond de Boer
Papers
1
Total Citations
6
H-Index
1
About
Raymond de Boer is a clinical researcher whose work centers on improving the safety and tolerability of breast cancer radiotherapy, with a particular focus on brachytherapy and skin toxicity reduction. His most notable contribution is the development and clinical testing of a hyaluronic acid spacer injection technique designed to increase the distance between the skin and the target volume during accelerated partial breast irradiation (APBI). This innovative approach aims to reduce skin dose and subsequent radiation-induced toxicity, addressing a critical limitation of certain APBI techniques. His 2018 study protocol for a randomized controlled trial on this method, which has garnered 6 citations, lays the groundwork for a practical intervention that could significantly enhance patient quality of life by minimizing painful skin reactions. De Boer’s work sits at the intersection of radiation oncology and biomedical engineering, offering a simple yet elegant solution to a common clinical problem. By targeting the primary risk factor for skin toxicity—skin dose—his research holds promise for making breast-conserving treatments safer and more widely applicable, reflecting a dedicated focus on translating technical innovation into tangible patient benefit.
Research Focus
Key Achievements
Top Papers
- 1